Developing a Patient Focused Discovery Process by Fostering Innovation
Upcoming SlideShare
Loading in...5
×
 

Developing a Patient Focused Discovery Process by Fostering Innovation

on

  • 682 views

Lora Bogoeva, Summit Producer of the marcus evans Discovery Summit 2011, shares her thoughts on fostering innovation in the drug discovery industry.

Lora Bogoeva, Summit Producer of the marcus evans Discovery Summit 2011, shares her thoughts on fostering innovation in the drug discovery industry.

Statistics

Views

Total Views
682
Views on SlideShare
682
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Developing a Patient Focused Discovery Process by Fostering Innovation Developing a Patient Focused Discovery Process by Fostering Innovation Document Transcript

  • 21 - 23 March 2011 | Majestic Barrière Hotel | Cannes | FranceDeveloping a Patient Focused DiscoveryProcess by Fostering Innovation Lora Bogoeva, Summit Producer of the marcus evans Discovery Summit 2011, shares her thoughts on fostering innovation in the drug discovery industry.FOR IMMEDIATE RELEASEThe blockbuster drug era is over! The once prosperous Radical advances are achieved each day. Pharma is no longerpharma industry that enjoyed tremendous growth and large an industry of products but one of information. New initiativesmonopoly profits is now in trouble. While in the past each are gaining popularity: data is being placed in the publiccompany chased financial rewards and kept important data in domain, where no hidden agenda can hinder the discoverysecrecy, the global pharmaceutical scenario now seeks to process.redefine its dynamics and diversify its global vision. Both public and private sector funding streams are heavilyIf we consider new drugs coming to market as innovations, investing in such projects to hit upon answers. A problemthen indeed the industry is trapped in what many refer to as shared is a problem halved and sharing the costs and risksthe innovation gap. This term has become the new scare word involved is what will lend a hand in this increasingly troubledand it is only by making full use of new and existing chemical state of affairs.and biological entities that cutting edge advances can beachieved and the gap could be closed. It is fascinating to witness how previously locked possibilities can be opened up through continuous research and extensiveSimply put, getting creative to overcome the recent collaboration. Impossible is nothing as even the species gap isproductivity crisis is the most talked about solution for the being narrowed in the battle of identifying new ways to testnecessary transformation. novel therapies.Profound leaders passionately discuss open innovation as a We are witnessing a tremendous heave as scientists across themeans to a happy end of the efficiency predicament. I wonder globe are adopting an exceptional approach. They no longerif it is a mere buzz word, or if it is really what will broaden our fear the challenges that lie ahead but explore them, togetherhorizon and improve treatment options for patients with the arising opportunities.worldwide? The marcus evans Discovery Summit 2011 will grantDespite the downturn and lack of recent achievements, participants the prospect of reaching across boundaries andpharma leaders remain optimistic and strongly believe that applying vision while creating an organisational structure thatthey have the ability to overcome this adversity by thinking supports the right focus.outside the box and looking for possibilities beyondpharmaceuticals. www.discovery-summit.com
  • 21 - 23 March 2011 | Majestic Barrière Hotel | Cannes | France Contact: Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division Tel: + 357 22 849 313 Email: press@marcusevanscy.com About the Discovery Summit 2011 This unique forum will take place at the Majestic Barrière Hotel, Cannes, France, 21 - 23 March 2011. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The summit includes presentations on ensuring successful drug discovery, stimulating innovation and creating partnerships. For more information please send an email to info@marcusevanscy.com or visit the event website at www.discovery-summit.com. marcus evans group - life sciences / pharma sector portal Please note that the summit is a closed business event and the number of participants strictly limited. About marcus evans Summits marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings. For more information, please visit www.marcusevans.com All rights reserved. The above content may be republished or reproduced – kindly inform us by sending an email to press@marcusevanscy.com www.discovery-summit.com